The U.S. has set itself the goal of developing 300 million doses of an approved COVID-19/SARS-CoV-2 vaccine by January 2021. They are pursuing their ambitious goal under the name “Operation Warp Speed”, based on the Starship Enterprise's faster-than-light speed. According to the U.S. Defense Department's website, which reports on Operation Warp Speed, four pharmaceutical companies have already entered phase 3 of the vaccine manufacturing process, among them AstraZeneca, Johnson & Johnson, Moderna, and Pfizer.
We are proud of the fact that U.S. pharmaceutical companies conducting vaccine research are among our customers. At the international level, we also support nearly any company that is currently developing a vaccine.
You can find all the information on Operation Warp Speed and the latest development news on the U.S. Department of Defense's website at https://www.defense.gov/Explore/Spotlight/Coronavirus/Operation-Warp-Speed/Operation-Warp-Speed-Timeline/